You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Protocols – Radiation Treatment

The following list provides an overview of evidence-based protocols for radiation treatment that are approved for use in Ontario.

For reporting purposes, use the list of active radiation treatment protocols available in the Data Book.

To review recent changes to the radiation treatment protocols, download the Summary of Radiation Treatment Protocol Changes.

To submit a new protocol for review, see Request a New or Modified Protocol.

Radiation QBP

269 items

LUNG_SHORT_1

Lung - Short course (1-2 fractions)

Cancer Type: Lung
Modality: EBRT
Dose (Gy):8-17
Fractionation: 1-2
Dose per Fraction(Gy):8-10
Apr 2020

LUNG_SHORT_2

Lung - Short course (3 fractions - 0, 7, 21)

Cancer Type: Lung
Modality: EBRT
Dose (Gy):18-24
Fractionation: 3
Dose per Fraction(Gy):6-8
Apr 2020

LUNG_SHORT_3

Lung - Short course (5-13 fractions)

Cancer Type: Lung
Modality: EBRT
Dose (Gy):20-39
Fractionation: 5-13
Dose per Fraction(Gy):3-4
Apr 2020

LUNG_THYMOMA_SBRT_FRAC

Lung - Thymoma SBRT fractionated

Cancer Type: Lung
Modality: SBRT
Dose (Gy):30-62
Fractionation: 3-8
Dose per Fraction(Gy):6-18
Apr 2020

LUNG_THYMOMA_SBRT_SINGLE

Lung - Thymoma SBRT single fraction

Cancer Type: Lung
Modality: SBRT
Dose (Gy):15-35
Fractionation: 1
Dose per Fraction(Gy):15-35
Apr 2020

LUNG_THYMOMA_STD

Lung - Thymoma standard fractionation

Cancer Type: Lung
Modality: EBRT
Dose (Gy):40-66
Fractionation: 15-33
Dose per Fraction(Gy):1.8-2
Apr 2020

NONNEO_AVMAL_FX

Non-neoplastic (CNS)-Arteriovenous malformations fractionated

Cancer Type: Non-Neoplastic (CNS)
Modality: SRS
Dose (Gy):20-30
Fractionation: 4-5
Dose per Fraction(Gy):5-6
Feb 2021

NONNEO_AVMAL_SRS

Non-neoplastic (CNS)-Arteriovenous malformations SRS

Cancer Type: Non-Neoplastic (CNS)
Modality: SRS
Dose (Gy):5-25
Fractionation: 1
Dose per Fraction(Gy):5-25
Feb 2021

NONNEO_BONE_HETERO_OSSIFIC

Non-neoplastic (Bone)- Heterotopic ossification conventional RT

Cancer Type: Non-Neoplastic
Modality: EBRT
Dose (Gy):5-20
Fractionation: 1-10
Dose per Fraction(Gy):2-8
Apr 2020

NONNEO_ENDO_GRAVES

Non-neoplastic (Endocrine)-Graves Disease

Cancer Type: Non-Neoplastic
Modality: EBRT
Dose (Gy):20
Fractionation: 10
Dose per Fraction(Gy):2
Jun 2021

NONNEO_KELOID_BRACHY_POSTOP

Non-neoplastic (Skin) - Benign other- keloid brachy

Cancer Type: Non-Neoplastic (Skin)
Modality: Brachy
Dose (Gy):18
Fractionation: 3
Dose per Fraction(Gy):6
Apr 2020

NONNEO_KELOID_EBRT_POSTOP

Non-neoplastic (Skin) - Benign other- keloid EBRT

Cancer Type: Non-Neoplastic (Skin)
Modality: EBRT
Dose (Gy):8-40
Fractionation: 1-5
Dose per Fraction(Gy):2.4-8
Apr 2020